The TB/HIV and community engagement unit of the World Health Organization (WHO)’s Global TB Programme focuses on development of relevant policies and strategies, guidelines and tools to address (1) HIV-associated TB (2) latent tuberculosis infection (3) integrated community-based TB activities including through effective engagement of nongovernmental and other civil society organizations, and (4) integration of TB prevention, treatment and care services to maternal, neonatal and child health services.

The World Health Organization’s Global TB Programme has developed operational guidance, The Essentials, for effective adaptation and implementation of the End TB Strategy.

May 24, 2016 - A new initiative seeking to develop new antibiotic treatments is being launched today at the annual World Health Assembly. The Global Antibiotic Research and Development (GARD) is a partnership between the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi).

New World Health Organization recommendations aim to speed up detection and improve treatment outcomes for multidrug-resistant TB through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.

The World Health Organization (WHO)’s Global TB Programme in collaboration with the Republic of Korea Centers for Disease Control and Prevention and the International Tuberculosis Research Center of Korea (ITRC) conducted a Global consultation meeting on the programmatic management of latent tuberculosis infection on April 27-28, 2016 in Seoul, Republic of Korea.

In advance of World TB Day, to be observed on March 24, the World Health Organization (WHO) is calling on countries and partners to "Unite to End Tuberculosis".

The World Health Organization (WHO)’s Global TB Program is establishing a Civil Society Task Force on TB (CSTF) to enhance the engagement of communities, non-governmental and other civil society organizations in the implementation of the End TB Strategy.

A new WHO report reviews progress and challenges in the global response to HIV, tuberculosis, malaria, hepatitis and neglected tropical diseases against the Millennium Development Goals, and identifies the strategies and approaches needed to accelerate progress during the new development era.

TB/HIV and community engagement unit of the World Health Organization (WHO)’s Global TB Programme coordinates the Department’s work on TB/HIV and the delivery of integrated community based TB activities through both national TB programmes and the engagement of non-governmental (NGO) and other civil society organisations (CSO) to integrate TB into their community-based work in HIV, maternal and child health, primary health care and other sectors such as education, agriculture and livelihood development programmes.

WHO consolidated guidelines: Integrating collaborative TB and HIV services within a comprehensive package of care for people who inject drugs